Detalhe da pesquisa
1.
The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
Br J Haematol
; 203(5): 840-851, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614192
2.
Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia.
Am J Hematol
; 98(12): 1869-1876, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688521
3.
Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell-Depleted Hematopoietic Cell Transplant.
J Infect Dis
; 225(3): 453-464, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390240
4.
Adenovirus Viral Kinetics and Mortality in Ex Vivo T Cell-Depleted Hematopoietic Cell Transplant Recipients With Adenovirus Infection From a Single Center.
J Infect Dis
; 222(7): 1180-1187, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374872
5.
Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.
Biol Blood Marrow Transplant
; 26(8): 1497-1504, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447045
6.
Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study.
Biol Blood Marrow Transplant
; 26(8): 1482-1491, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315708
7.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618690
8.
Drugs as a Frequent Cause of Acute Rash in Patients after CD34+-Selected Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2172-2180, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306779
9.
Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes.
Biol Blood Marrow Transplant
; 25(4): 791-799, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30476551
10.
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1526-1535, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30831208
11.
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1136-1141, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625387
12.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423480
13.
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations.
Br J Haematol
; 184(6): 1006-1010, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30537212
14.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381298
15.
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
Transpl Infect Dis
; 21(6): e13187, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585500
16.
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): 2517-2522, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30055353
17.
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 142-149, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951193
18.
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 133-141, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870777
19.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325829
20.
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .
Biol Blood Marrow Transplant
; 24(5): 964-972, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305194